Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 646 AL 660

RyR2-dependent modulation of neuronal hyperactivity: A potential therapeutic target for treating Alzheimer's disease

Yao J, Chen SRW.

J Physiol. 2024 Apr;602(8):1509-1518. doi: 10.1113/JP283824. Epub 2023 Mar 14.

Alzheimer's Disease and COVID-19 Pathogenic Overlap: Implications for Drug Repurposing

Golzari-Sorkheh M, Liyanage I, Reed MA, Weaver DF.

Can J Neurol Sci. 2024 Mar;51(2):161-172. doi: 10.1017/cjn.2023.39. Epub 2023 Mar 30.

An insight into structure-activity relationship of naturally derived biological macromolecules for the treatment of Alzheimer's disease: a review

Halder D, Das S, Joseph A.

J Biomol Struct Dyn. 2024 Aug;42(12):6455-6471. doi: 10.1080/07391102.2023.2230279. Epub 2023 Jun 28.

Transcranial pulse stimulation in Alzheimer's disease

Chen X, You J, Ma H, Zhou M, Huang C.

CNS Neurosci Ther. 2024 Feb;30(2):e14372. doi: 10.1111/cns.14372. Epub 2023 Jul 20.

Impact of dance interventions on the symptoms of dementia: A mixed-methods systematic review

Manji I, Wells S, Dal Bello-Haas V, Fallavollita P.

Arts Health. 2024 Feb;16(1):64-88. doi: 10.1080/17533015.2023.2242390. Epub 2023 Aug 9.

Updates on pharmacological treatment for Alzheimer's disease

Tipton PW.

Neurol Neurochir Pol. 2024;58(2):150-160. doi: 10.5603/pjnns.96286. Epub 2023 Aug 22.

Triptolide activates the Nrf2 signaling pathway and inhibits the NF-κB signaling pathway to improve Alzheimer disease

He Z, Botchway BOA, Zhang Y, Liu X.

Metab Brain Dis. 2024 Jan;39(1):173-182. doi: 10.1007/s11011-023-01278-4. Epub 2023 Aug 25.

Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets

Paniri A, Hosseini MM, Akhavan-Niaki H.

Mol Neurobiol. 2024 Mar;61(3):1282-1317. doi: 10.1007/s12035-023-03626-y. Epub 2023 Sep 12.

Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease

Kron JOJ, Keenan RJ, Hoyer D, Jacobson LH.

Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:359-386. doi: 10.1146/annurev-pharmtox-040323-031929. Epub 2023 Sep 14.

NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease

Li L, Jin M, Tan J, Xiao B.

CNS Neurosci Ther. 2024 Apr;30(4):e14476. doi: 10.1111/cns.14476. Epub 2023 Sep 22.

Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review

Golmohammadi M, Mahmoudian M, Hasan EK, Alshahrani SH, Romero-Parra RM, Malviya J, Hjazi A, Najm MAA, Almulla AF, Zamanian MY, Kadkhodaei M, Mousavi N.

Fundam Clin Pharmacol. 2024 Apr;38(2):225-237. doi: 10.1111/fcp.12955. Epub 2023 Sep 27.

Alzheimer's Disease: A Review of Pathology, Current Treatments, and the Potential Therapeutic Effect of Decreasing Oxidative Stress by Combined Vitamin D and l-Cysteine Supplementation

Jain SK, Stevens CM, Margret JJ, Levine SN.

Antioxid Redox Signal. 2024 Apr;40(10-12):663-678. doi: 10.1089/ars.2023.0245. Epub 2023 Dec 8.

Memantine: Updating a rare success story in pro-cognitive therapeutics

Karimi Tari P, Parsons CG, Collingridge GL, Rammes G.

Neuropharmacology. 2024 Feb 15;244:109737. doi: 10.1016/j.neuropharm.2023.109737. Epub 2023 Oct 11.

The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review

Arjmandi-Rad S, Vestergaard Nieland JD, Goozee KG, Vaseghi S.

Neurol Sci. 2024 Feb;45(2):417-430. doi: 10.1007/s10072-023-07114-y. Epub 2023 Oct 16.

Transcranial direct current stimulation for global cognition in Alzheimer's disease: a systemic review and meta-analysis

Wang X, Tian L.

Neurol Sci. 2024 Mar;45(3):883-895. doi: 10.1007/s10072-023-07162-4. Epub 2023 Nov 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias